C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 403/12 (2006.01) A61K 31/506 (2006.01) A61K 31/53 (2006.01) A61P 35/00 (2006.01) C07D 215/42 (2006.01) C07D 215/46 (2006.01) C07D 251/18 (2006.01) C07D 251/52 (2006.01) C07D 251/54 (2006.01) C07D 251/70 (2006.01) C07D 401/12 (2006.01) C07D 401/14 (2006.01)
Patent
CA 2392507
The invention concerns cancer therapy and novel anti-cancer agents having a very particular mechanism. The invention also concerns novel chemical compounds and their therapeutic use in humans.
La présente invention est relative à la thérapie du cancer et concerne de nouveaux agents anticancéreux ayant un mécanisme d'action bien particulier. Elle concerne aussi de nouveaux composés chimiques ainsi que leur application thérapeutique chez l'homme.
Laoui Abdelazize
Lavelle Francois
Mailliet Patrick
Mergny Jean-Louis
Petitgenet Odile
Aventis Pharma S.a.
Robic
LandOfFree
Arylamine derivatives and their use as anti-telomerase agent does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Arylamine derivatives and their use as anti-telomerase agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Arylamine derivatives and their use as anti-telomerase agent will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1527847